Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity

Neuropharmacology

Volumn 36, Issue 8, 1997, Pages 1115-1117

  Marin, C ^a   Tolosa, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dopamine; Neuroleptic; Stereotyped behavior; Supersensitivity; Synaptic density; Synaptophysin

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; HALOPERIDOL; MARKER; NEUROLEPTIC AGENT; QUINPIROLE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DOSE TIME EFFECT RELATION; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION; SUPERSENSITIVITY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; HALOPERIDOL; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOTYPED BEHAVIOR; SYNAPTOPHYSIN;

EID: 0030741830     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00097-X     Document Type: Article

References (18)

1. Alford M. F., Masliah E., Hansen L. A. and Terry R. D. (1994) A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. Journal of Histochemistry and Cytochemistry 42: 283-287.
2. Eastwood S. L., Burnet P. W. J., McDonald B., Clinton J. and Harrison P. J. (1994) Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience 59: 881-892.
3. Eastwood S. L., Burnet P. W. J. and Harrison P. J. (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66: 309-319.
4. Ernst A. M. (1967) Mode of action of apomorphine. Psychopharmacologia 10: 316-323.
5. Harrison, P. J. (1993) Effects of neuroleptics on neuronal and synaptic structure. In Antipsychotic Drugs and their Side Effects (Barnes T. R. E., Ed.), pp. 99-110. Academic Press, London.
6. Kerns J. M., Sierens D. K., Chiung Kao L., Klawans H. L. and Carvey P. M. (1992) Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clinical Neuropharmacology 15: 488-500.
7. Klawans H. L. and Rubovits R. (1972) An experimental model of tardive dyskinesia. Journal of Neural Transmission 33: 235-246.
8. LaHoste G. J. and Marshall J. F. (1992) Dopamine supersensitivity and D-1/D-2 synergism are unrelated to changes in striatal receptor density. Synapse 12: 14-26.
9. LaHoste G. J., Yu J. and Marshall J. F. (1993) Striatal fos expression is indicative of dopamine D-1/D-2 synergism and receptor supersensitivity. Proceedings of the National Academy of Science U.S.A. 90: 7451-7455.
10. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1952) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 269-275.
11. Marin C. and Chase T. N. (1993) Dopamine D-1 stimulation but not dopamine D-2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor-upregulation. European Journal of Pharmacology 231: 191-196.
12. Marin C., Bonastre M. and Tolosa E. (1996) Striatal c-fos levels do not correlate with haloperidol-induced behavioral supersensitivity. Synapse 23: 89-93.
13. Marsden, C. D., Tarsy, D., and Baldessarini, R. J. (1975) Spontaneous and drug-induced movements disorder in psychotic patients. In Psychiatric Aspects of Neurologic Diseases (Benson and D. F. and Blumer D. Eds), p. 219. Grune and Stratton, New York.
14. Meshul C. K., Stalbaumer R. K., Taylor B. and Janowsky A. (1994) Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Research 648: 181-195.
15. Okada M., Erikson A. and Hendrickson A. (1994) Light and electron microscopic analysis of synaptic development in Macaca monkey retina as detected by immunocytochemical labelling for the synaptic vesicle protein, SV2. Journal of Comparative Neurology 339: 535-558.
16. Parashos S. A., Barone P., Marin C., Paraschos A. J., Kapitzoglou-Logothetis V. and Chase T. N. (1989) Haloperidol and SCH23390-induced dopaminergic supersensitivities are not additive in the rat. Psychopharmacology (Berl) 98: 189-192.
17. Sirinathsinghji D. J. S., Schuligoi R., Hearens R. P., Dixon A., Iversen S. D. and Hin R. G. (1994) Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D-2 receptor antagonist. Neuroscience 62: 407-423.
18. Tarsy D. and Baldessarini R. S. (1974) Behavioral hypersensitivity to apomorphine following chronic treatment with drugs which interfere with synaptic function of catecholamines. Neuropharmacology 13: 927-940.